[
    {
        "entity_name": "Inflammatory bowel disease (IBD)",
        "type": "Disease",
        "description": "A group of inflammatory conditions of the gastrointestinal tract, primarily affecting the colon and small intestine.",
        "is_ambiguous": false
    },
    {
        "entity_name": "TNF-\u03b1-antagonists",
        "type": "Drug",
        "description": "A class of medications that inhibit tumor necrosis factor-alpha, used in the treatment of autoimmune diseases including IBD.",
        "is_ambiguous": false
    },
    {
        "entity_name": "Bifidobacterium",
        "type": "Gene",
        "description": "A genus of bacteria that is beneficial to gut health and is often associated with higher expression of metabolism-related genes.",
        "is_ambiguous": false
    },
    {
        "entity_name": "Bacteroides",
        "type": "Gene",
        "description": "A genus of bacteria that is associated with increased metallothionein signaling in the gut.",
        "is_ambiguous": false
    },
    {
        "entity_name": "Lachnoclostridium",
        "type": "Gene",
        "description": "A genus of bacteria associated with immunoregulatory genes in non-stenotic tissue of IBD patients.",
        "is_ambiguous": false
    },
    {
        "entity_name": "Ruminococcaceae",
        "type": "Gene",
        "description": "A family of bacteria linked to fatty acid metabolism genes in patients using TNF-\u03b1-antagonists.",
        "is_ambiguous": false
    },
    {
        "entity_name": "metallothionein signaling",
        "type": "Protein",
        "description": "A signaling pathway involving metallothionein proteins that may play a role in intestinal health and disease.",
        "is_ambiguous": true
    },
    {
        "entity_name": "fatty acid metabolism",
        "type": "Protein",
        "description": "A metabolic pathway involving the breakdown and synthesis of fatty acids, significant in the context of IBD and treatment.",
        "is_ambiguous": true
    }
]